SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-060967
Filing Date
2018-11-20
Accepted
2018-11-20 09:57:11
Documents
1
Period of Report
2018-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv507656_form3.html 3  
1 FORM 3 tv507656_form3.xml 3 4170
  Complete submission text file 0001144204-18-060967.txt   5611
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KOGETO, INC. 51 WOOSTER ST., 2ND FLOOR NEW YORK NY 10013
Business Address
Clark John P (Reporting) CIK: 0001607547 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36602 | Film No.: 181194552